Takeda’s USD 4bn psoriasis pill helped clear skin in mid-stage study
![](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13500092.ece/ALTERNATES/schema-16_9/takeda.jpg)
Takeda Pharmaceutical Co.’s newly purchased oral psoriasis drug was safe and effective in a mid-stage study, highlighting its potential for treating the painful, incurable skin condition.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Leo Pharma books multimillion-dollar loss in 2022
For subscribers